Lithium exposure and chronic inflammation with activated macrophages and monocytes associated with atherosclerosis in bipolar disorder

Medicine and Dentistry

• Chronic Inflammation 100%
• Macrophage 100%
• Atherosclerosis 100%
• Intima-Media Thickness 100%
• Monocyte 100%
• Bipolar Disorder 100%
• Bipolar I Disorder 66%
• Cardiovascular Disease 50%
• Endocrine Disease 33%
• Tumor Necrosis Factor Receptor 1 33%
• Interleukin 6 Receptor 33%
• Disease 16%
• Drug Therapy 16%
• Body Mass Index 16%
• Monocyte Chemotactic Protein 1 16%
• Adhesive Agent 16%
• Protective Factor 16%
• Chronicity 16%
• Thrombin Antithrombin Complex 16%
• Psychopharmacotherapy 16%
• Chitinase 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Atherosclerosis 100%
• Chronic Inflammation 100%
• Bipolar Disorder 100%
• Bipolar I Disorder 80%
• Cardiovascular Disease 60%
• Tumor Necrosis Factor Receptor 1 40%
• Interleukin 6 Receptor 40%
• Endocrine Disease 40%
• Monocyte Chemotactic Protein 1 20%
• Adhesive Agent 20%
• Thrombin Antithrombin Complex 20%
• Chronicity 20%
• Psychopharmacotherapy 20%
• Disease 20%
• Chitinase 20%

Neuroscience

• Bipolar Disorder 100%
• Bipolar I Disorder 100%
• Macrophage 100%
• Endocrine Disease 50%
• Interleukin-6 Receptor 50%
• Tumor Necrosis Factor Receptor 1 50%
• Thrombin 25%
• Body Mass Index 25%
• Monocyte Chemotactic Protein 1 25%
• Antithrombin 25%
• Chitinase 25%